Ocular Therapeutix (OCUL) PT Raised to $11 at Raymond James
Tweet
Share
E-mailGet Alerts OCUL Hot Sheet
Price: $10.65 +6.08%
Rating Summary:
20 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
20 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Raymond James analyst Dane Leone raised the price target on Ocular Therapeutix (NASDAQ: OCUL) to $11.00 (from $10.00) while maintaining a Strong Buy rating following FDA approval.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Raymond James, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
